Gene Prediction Tools Market Size was valued at USD 0.15 Billion in 2022. The Gene Prediction Tools Market industry is projected to grow from USD 0.17 Billion in 2023 to USD 0.68 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 18.20% during the forecast period (2024 - 2032). Advances in genomics research, increased use of personalized medicine, and rising demand for bioinformatics solutions are expected to be significant market drivers for gene prediction tools.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Gene Prediction Tools Market Trends
Market CAGR for gene prediction tools is driven by the rising demand for personalized medicines and growing applications of genomics. The growing demand for personalized medicine has been a catalyst for the advancement of gene prediction tools. These tools leverage genetic information to forecast an individual's susceptibility to certain diseases, their response to specific medications, and potential adverse reactions. By analyzing an individual's genetic data, gene prediction tools can identify variations linked to diseases or drug metabolism, thus assisting in tailoring treatment plans. Additionally, numerous collaborations among researchers and industry stakeholders are expected to positively influence market growth. For instance, in February 2022, Genomic Medicine Sweden (GMS) and the Centers for Personalized Medicine (ZPM) in Germany joined forces for strategic, structural, and content-specific initiatives aimed at implementing precision medicine in healthcare.
Future trends in genomic engineering encompass its utilization in marine engineering for purposes such as the extraction of nutraceuticals from algae. Other emerging application domains include forensic sciences and personalized medicine. Next-generation sequencing (NGS) finds utility in DNA barcoding for the identification of fish larvae and eggs, alongside providing comprehensive descriptions of fish communities during the evaluation of fish populations. Genomics is progressively integrated into food quality and safety testing. Genome editing technologies play crucial roles in drug discovery as well as the diagnosis and treatment of human genetic disorders. Additionally, genome editing is employed in NGS, DNA analysis, profiling, and the genetic engineering of plants and animals. Consequently, as genomics continues to diversify its application areas, the demand for genome editing technologies is anticipated to rise in the forecast period. As a result, it is anticipated that throughout the projection period, demand for the Gene Prediction Tools Market will increase due to the increasing pressure among working individuals and Rising demand and increasing legalization of cannabis. Thus, driving the Gene Prediction Tools Market revenue.
Gene Prediction Tools Market Segment Insights
The Gene Prediction Tools Market segmentation, based on Components, includes Software and Service. The software segment dominated the market, accounting for 58% of market revenue. The growth trajectory is shaped by advancing technologies and evolving global research requirements. For instance, to enhance gene prediction accuracy and functional annotation, algorithms are increasingly integrating multi-omics data, including transcriptomics, epigenomics, and proteomics. Integrating multiple layers of omics data enables a deeper comprehension of gene regulation and functional connections. Continuous endeavors to enhance gene prediction accuracy represent pivotal advancements in software development. Furthermore, addressing the challenges of handling complex genomic data and designing user-friendly and educational interfaces for academics and clinicians would further drive demand.
Figure 1: Gene Prediction Tools Market, by Components, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Gene Prediction Tools Market Application Insights
The Gene Prediction Tools Market segmentation, based on Application, includes Drug discovery & designing, Diagnostics, and other applications. The drug discovery & designing segment dominated the market, accounting for 58% of market revenue. Complex disorders such as cancer, cardiovascular diseases, and neurological disorders are characterized by intricate genetic factors. Gene prediction tools are instrumental in researchers and pharmaceutical companies elucidating the genetic foundations of these diseases. Through the identification of pertinent genes and pathways, these tools enable the discovery of potential drug targets, thereby facilitating the development of more efficacious therapeutics.
Gene Prediction Tools Market End-user Insights
The Gene Prediction Tools Market segmentation, based on End-user, includes Research & academic institutes, Biotechnology companies, Hospitals & clinics, and Diagnostic laboratories. The research & academic institutes segment dominated the market, accounting for 60% of market revenue. Due to their involvement in genomics research and biological inquiries, academic institutes and research centers possess diverse needs for gene prediction tools. Accurately pinpointing genes within a genome, annotating their attributes, and projecting their functions are essential tasks facilitated by gene prediction methodologies. These tools play a pivotal role in comprehending the genetic composition of species and exploring their evolutionary connections.
Gene Prediction Tools Market Regional Insights
By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The anticipated expansion of the Gene Prediction Tools market in North America can be attributed to several key factors. The escalating demand for gene prediction tools in the United States can be attributed to the country's burgeoning genomic research landscape. With a thriving community dedicated to genomics research, encompassing initiatives such as genome sequencing, genetic disease exploration, and population genetics studies, the need for advanced tools has grown significantly. The National Institutes of Health's All of Us Research Program, boasting nearly 100,000 diverse whole genome sequences, exemplifies this trend. Additionally, the Government of Canada's investment of $15 million over five years in the Pan-Canadian Genomic Library marks its inaugural step toward establishing a national, centralized genomic data management system. This initiative aims to enable healthcare professionals to securely capture, store, and access Canadian data equitably and sustainably. Gene prediction software plays a pivotal role in delineating gene architectures, regulatory elements, and functional annotations within extensive genomic datasets. Consequently, with the expansion of genomics research and applications, the demand for gene prediction software is expected to surge in the United States.
Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: GENE PREDICTION TOOLS MARKET SHARE BY REGION 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe's Gene Prediction Tools Market accounts for the second-largest market share, as Europe has led the way in genomic research and technological advancements. The ongoing progress in sequencing technologies and bioinformatics tools has spurred a growing need for precise and effective gene prediction tools. In response, the government has announced substantial investments, including up to £25 million in Medical Research Council-led funding for a four-year functional genomics initiative. This initiative, in collaboration with UK Research and Innovation and other stakeholders, aims to establish a globally competitive offering in functional genomics through partnerships with industry, leveraging existing infrastructure and the expertise of UK researchers. Further, the German Gene Prediction Tools Market held the largest market share, and the UK Gene Prediction Tools Market was the fastest-growing market in the European region.
The Asia-Pacific Gene Prediction Tools Market is expected to grow at the fastest CAGR from 2024 to 2032. Increased healthcare expenditure, growing research endeavors, advancements in technology, and the proliferation of various research tools are driving the expansion of the gene prediction tool market in the region. India facilitates 100% Foreign Direct Investment (FDI) through the automatic route for greenfield pharmaceuticals and medical device manufacturing, eliminating the need for government approval for non-resident or Indian companies. In December 2023, the Gujarat Chief Minister inaugurated the 'Start-Up Product Launch' event, showcasing innovative products developed by startups like Bioscan, SynerSense, Iota, and STRUmed Solutions during the 10th Vibrant Gujarat Global Summit. The Pre-Summit also witnessed the signing of a Memorandum of Understanding (MoU) between Indus Setu Global Foundation and Gujarat State Biotechnology Mission. Additionally, in November 2023, Bharat Biotech entered into an MoU with the University of Sydney Infectious Diseases Institute (Sydney ID) to collaborate on vaccine research initiatives, strengthening academic-industry partnerships. Moreover, China’s Gene Prediction Tools Market held the largest market share, and the Indian Gene Prediction Tools Market was the fastest-growing market in the Asia-Pacific region.
Gene Prediction Tools Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development to expand their product lines, which will help the Gene Prediction Tools market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Gene Prediction Tools industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Gene Prediction Tools industry to benefit clients and increase the market sector. In recent years, the Gene Prediction Tools industry has offered some of the most significant advantages to the fields of healthcare, biotechnology, and genomic research. Major players in the Gene Prediction Tools Market, including AzoLifeScience, Softberry Technologies, DNASTAR, Qiagen NV, Illumina, Inc., BGI Genomics, Genscript, Exiqon, Geneious, Thermo Fisher Scientific, Inc. are attempting to increase market demand by investing in research and development operations.
Thermo Fisher Scientific Inc. is a leading provider of medical equipment, analytical instruments, reagents, consumables, software, and services designed to address complex analytical challenges across research, diagnostics, and clinical laboratories. Their offerings encompass solutions for cellular analysis, biology, flow cytometry, and synthetic biology. The company boasts a diverse product range, including technologies for mass spectrometry, genetic sequencing, electron microscopy, protein research, and molecular biology. Thermo Fisher serves a wide spectrum of clients, including pharmaceutical and biotech companies, academic and research institutions, clinical diagnostic labs, government agencies, as well as the environmental and industrial quality and process control sectors. They distribute their products and services through direct sales, e-commerce platforms, and third-party distributors across the Americas, Asia-Pacific, and Europe. Thermo Fisher, headquartered in Waltham, Massachusetts, USA, recently announced the introduction of the Gibco CTS AAV-MAX Helper-Free AAV Production System in November 2022. This comprehensive solution is tailored for commercial and clinical applications related to AAV-based gene therapies.
Illumina Inc. specializes in providing genomic sequencing and array-based solutions for genetic analysis across various sectors, including molecular diagnostics, translational and consumer genomics, and cancer research. Their product portfolio includes sequencing kits, reagents, tools, and systems, as well as microarray kits, molecular biology reagents, and arrays. Illumina offers services such as human whole-genome sequencing, microarray services, and instrument services alongside training and consulting. Their clientele includes pharmaceutical companies, academic institutions, genomic research centers, biotechnology firms, and clinical research organizations. The company distributes its products through direct sales and a network of distributors spanning the Americas, Asia-Pacific, Europe, the Middle East, and Africa. Illumina is headquartered in San Diego, California, USA.
Key companies in the Gene Prediction Tools Market include
Gene Prediction Tools Industry Developments
November 2022: DNASTAR announced the release of Lasergene 17.4, which introduces an array of added functionalities focused on variant analysis for multiple sequence alignments.
June 2023: Illumina, Inc. unveiled the Al software designed for predicting genetic mutations responsible for patient diseases. This move has bolstered the company's product lineup and contributed to its revenue expansion.
Gene Prediction Tools Market Segmentation
Gene Prediction Tools Market Component Outlook
Gene Prediction Tools Market Application Outlook
Gene Prediction Tools Market End-user Outlook
Gene Prediction Tools Market Regional Outlook
Asia-Pacific
Rest of the World
| Market Size 2022 | USD 0.15 Billion |
| Market Size 2023 | USD 0.17 Billion |
| Market Size 2032 | USD 0.68 Billion |
| Compound Annual Growth Rate (CAGR) | 18.20% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2019-2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Component, Application, End-user, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | AzoLifeScience, Softberry Technologies, DNASTAR, Qiagen NV, Illumina, Inc., BGI Genomics, Genscript, Exiqon, Geneious, Thermo Fisher Scientific, Inc |
| Key Market Opportunities | · Substantial investment in integrating various types of omics data, such as transcriptomics, epigenomics, and proteomics |
| Key Market Dynamics | · The ability of gene prediction tools to assist in the identification of genes responsible for diseases, genetic variations, and potential targets for drug development |
Frequently Asked Questions (FAQ) :
The Gene Prediction Tools Market size was valued at USD 0.17 Billion in 2023.
The Gene Prediction Tools Market is projected to grow at a CAGR of 18.20% during the forecast period 2024-2032.
North America had the largest share of the global market
The key players in the market are AzoLifeScience, Softberry Technologies, DNASTAR, Qiagen NV, Illumina, Inc., BGI Genomics, Genscript, Exiqon, Geneious, Thermo Fisher Scientific, Inc.
The Software segment dominated the market in 2023.
The Drug discovery & designing segment had the largest share of the global market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
